We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Short Technical ReportsOpen Accesscc iconby icon

Immunobead RT-PCR: A Sensitive Method for Detection of Circulating Tumor Cells

    Michael C. Eaton

    University of Adelaide, The Queen Elizabeth Hospital, Woodville, SA, Australia

    ,
    Jennifer E. Hardingham

    University of Adelaide, The Queen Elizabeth Hospital, Woodville, SA, Australia

    ,
    Dusan Kotasek

    University of Adelaide, The Queen Elizabeth Hospital, Woodville, SA, Australia

    &
    Alexander Dobrovic

    *Address correspondence to Alexander Dobrovic, Department of Haematology-Oncology, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia. Internet:

    E-mail Address: adobrovic@medicine.adelaide.edu.au

    University of Adelaide, The Queen Elizabeth Hospital, Woodville, SA, Australia

    Published Online:https://doi.org/10.2144/97221st01

    Detection of circulating tumor cells and micrometastases in patients with cancer should prove useful in determining prognosis and in planning and monitoring systemic therapies. We have developed immunomagnetic isolation of carcinoma cells followed by reverse transcription polymerase chain reaction (immunobead RT-PCR) as a method for identifying very small numbers of breast cancer cells in blood. The expression of cytokeratin 19 (K19) was used as the marker by which the isolated tumor cells were identified. The immunobead RT-PCR technique allowed detection of one tumor cell per 106 leukocytes in whole blood. Immunobead RT-PCR is a highly sensitive method of detecting cancer cells in a hematopoietic environment.